Z-0002-2023 Class I Terminated

Recalled by Fresenius Kabi USA, LLC — North Andover, MA

FDA device recall Z-0002-2023 was initiated by Fresenius Kabi USA, LLC on Sep 8, 2022 and is designated Class I. Reason for recall: The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen… The recall status is terminated (terminated Sep 10, 2024). Affected quantity: 4 instances.

Recall Details

Product Type
Devices
Report Date
Oct 12, 2022
Initiation Date
Sep 8, 2022
Termination Date
Sep 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 instances

Product Description

Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0

Reason for Recall

The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does not indicate an alarm condition or respond. This issue leads to temporary cessation of flow of a medication or fluid, requiring immediate intervention by the clinician.

Distribution Pattern

Domestic distribution to NJ and WI.

Code Information

UDI-DI: 00811505030122 version 5.2.0

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0002-2023
openFDA file date
Oct 6, 2026
Loaded by RegDataLab
Oct 12, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it. FDA may have changed the recall since.